Results of a study showed that for LASIK patients needing enhancement for which a flap lift may be difficult, PRK is safe and effective.
Meibomian gland dysfunction (MGD) is a common finding among patients who seek eyecare. In many patients, the disease is completely asymptomatic. In others, the severity can range from being a mild annoyance to significantly impacting vision and quality of life.
Adenoviral conjunctivitis can be tricky for practitioners because of the challenges associated with diagnosing and treating. Patients often come in with non-specific symptoms, so differentiating between bacterial and viral infections, as well as finding a treatment to manage the issue, is vital.
The correction of high myopia is limited, but phakic IOLs do provide a surgical option. "For many years we have been looking for a quality anterior chamber phakic IOL that could be easily performed in a clean room rather than an operating room," said Eric D. Donnenfeld, MD, partner at Ophthalmic Consultants of Long Island, Rockville Centre, N.Y., and clinical professor of ophthalmology, New York University Medical School.
The best way to treat negative dysphotopsia remains a hot topic among surgeons. Negative dysphotopsia that occurs right after cataract surgery is usually best left to resolve on its own. However, if the problem continues a few months after surgery, ophthalmologists must step in to provide a treatment. Their treatment approach usually depends on what they suspect is the cause.
The visual disturbances exacerbated by ocular surgery can range from annoying to disabling.
Using artificial tears is a fact of life for many patients with dry eye disease, according to Vincent P. de Luise, MD. Debra Schaumberg, ScD, OD, from the Harvard School of Public Health, has reported that between 25 and 40 million Americans have some level of dry eye, Dr. de Luise said, and virtually all of these patients are using artificial tears.
A retrospective analysis suggests oral azithromycin may be beneficial.
The success of any surgical intervention depends as much on postoperative care and management as it does on the surgical procedure itself. This undoubtedly also holds true for corneal crosslinking. At our hospital, we have been performing corneal crosslinking with the IROC illumination system since the development of the first prototype and continue to use the latest UV-X 2000 crosslinking device.
When will my vision stabilize after crosslinking? Could my keratoconus symptoms return? What complications might occur? Patients undergoing crosslinking have many questions, and CXL pros have the answers.